MabCure, Inc.
MabCure, Inc. (MBCI) Stock Overview
Explore MabCure, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
29.3K
P/E Ratio
-0.00
EPS (TTM)
$-0.03
ROE
-1.27%
MBCI Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of MabCure, Inc. (MBCI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 42.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.00 and a market capitalization of 29.3K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.